Drug Profile
Research programme: peripheral analgesics - AfaSci
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator AfaSci
- Class Analgesics; Peptides; Small molecules
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Inflammatory pain; Neuropathic pain; Postoperative pain
Highest Development Phases
- No development reported Inflammatory pain; Neuropathic pain; Postoperative pain
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Inflammatory-pain in USA
- 28 Aug 2020 No recent reports of development identified for preclinical development in Neuropathic-pain in USA
- 28 Aug 2020 No recent reports of development identified for preclinical development in Postoperative-pain in USA